alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                  GENWORTH LIFE INSURANCE COMPANY OF NEW YORK

                         SURRENDER CHARGE ENDORSEMENT

This endorsement is effective on the Contract Date. It amends the Definitions
section by deleting the Surrender Value definition and adding the following:

Surrender Value - The Contract Value on the date we receive your written
request for surrender in our Service Center less any premium tax and charges.
These charges include any surrender charge.

The Contract Value Benefits section is amended by deleting the Withdrawal
provision and adding the following:

Withdrawal

You may take a withdrawal from the Contract Value prior to the Annuity
Commencement Date. The allowable withdrawal amount is subject to limitations as
shown on the Contract Data Pages. The amount payable to you will be the amount
of the withdrawal, less any surrender charge and premium tax.

You may tell us how to deduct the withdrawal from the Investment Options. If
you do not, the withdrawal will be deducted from the Investment Options on a
prorata basis. A Portfolio may impose a redemption charge on Subaccount assets
that are redeemed from the Portfolio in connection with a withdrawal. The
Portfolio determines the amount of the redemption charge. The charge is
retained by or paid to the Portfolio. The charge is not retained by or paid to
us. The redemption charge may affect the number and/or value of Accumulation
Units withdrawn from the Subaccount that invests in that Portfolio and may
affect Contract Value.

Surrender Charge

All or part of the amount withdrawn or surrendered may be subject to a
surrender charge. The surrender charge is a percentage of each Purchase
Payment. The applicable percentage for each Purchase Payment is shown in the
Table of Surrender Charges on the Contract Data Pages. The number of years
shown in the table represents the number of full and partially completed years
since the Purchase Payment was received.

NY5345 3/07                           1

<PAGE>

For each Contract year, an amount equal to the free withdrawal amount may be
withdrawn during each Contract year without a surrender charge (the "free
withdrawal amount"). The free withdrawal amount is defined on the Contract Data
Pages. Any amount withdrawn in excess of the free withdrawal amount may be
subject to a surrender charge. For purposes of determining the applicable
surrender charge, the amount subject to a surrender charge will be deducted
from Purchase Payments on a first-in, first-out basis. Amounts withdrawn that
are not subject to surrender charge may be taken as a series of periodic
payments instead of a lump sum.

For Genworth Life Insurance Company of New York,

                                                  [/s/ David J. Sloane
                                                  ------------------------------
                                                  David J. Sloane
                                                  President]

NY5345 3/07                           2
| (1) | the      quarterly report on Form 10-KSB of Victory Eagle Resources Corp. for the      year ended July 31, 2006 (the "Report") fully complies with the      requirements of Section 13(a) or 15(d) of the Securities Exchange Act of      1934; and |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | the      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of Victory      Eagle Resources Corp. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | /s/ Ludvik    Rolin                                                                                                                                                   |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | Ludvik      Rolin                                                                                                                                                     |
|   | President,      Chief Executive Officer (Principal Executive Officer) Chief Financial      Officer(Principal Financial Officer and Principal Accounting      Officer) |

----
**Exhibit 32.1**

**Certification ofQuarterly Report**

I, Gerald McMahon,President and Chief Executive Officer of Poniard Pharmaceuticals, Inc.(the “Company”), certify, pursuant to Section 906 of the Sarbanes-OxleyAct of 2002, 18 U.S.C. 1350 that:

a.                 the QuarterlyReport on Form 10-Q for the quarter ended June 30, 2006 (the “Report”)fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

b.                theinformation contained in the Report 10-Q fairly presents, in all materialrespects, the financial condition and results of operations of the Company.
| Date: August 14, 2006 | By:    | /s/ GERALD MCmAHON |   |
|----------------------------|--------|--------------------|--------|
|                       |   | Gerald McMahon     |   |

 

----
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2487 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2487

    To suspend temporarily the duty on 2-cyclo-hexylidene-2-phenyl-
                             acetonitrile.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 26, 2012

 Mr. Brown of Ohio introduced the following bill; which was read twice 
                and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To suspend temporarily the duty on 2-cyclo-hexylidene-2-phenyl-
                             acetonitrile.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 2-CYCLO-HEXYLIDENE-2-PHENYL-ACETONITRILE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      2-cyclo-hexylidene- Free         No change        No change        On or before 12/  ''.
                        2-phenyl-                                                          31/2015.......
                        acetonitrile (CAS
                        No. 10461-98-0)
                        (provided for in
                        subheading
                        2926.90.43)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Corey A. McDowell BEY, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-400

District Court of Appeal of Florida, Second District.

Opinion filed November 22, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 4.1 Specimen Stock Certificate


Exhibit 4.1




















2
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2904 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2904

 To extend the temporary suspension of duty on 2-phenylbenzimidazole-5-
                             sulfonic acid.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Mr. Menendez introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To extend the temporary suspension of duty on 2-phenylbenzimidazole-5-
                             sulfonic acid.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 2-PHENYLBENZIMIDAZOLE-5-SULFONIC ACID.

    (a) In General.--Heading 9902.01.35 of the Harmonized Tariff 
Schedule of the United States (relating to 2-phenylbenzimidazole-5-
sulfonic acid) is amended by striking the date in the effective period 
column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Summary of 2007 Named Executive Officer Compensation



 Exhibit 10.38 
 Summary of 2008 Named Executive Officer Compensation 
 The following shows the current annual salary for
eLoyalty’s President and Chief Executive Officer, the current Chief Financial Officer, the previous Chief Financial Officer and each of the next three most highly compensated executive officers: 
  

				
	 Kelly D. Conway, President and Chief Executive Officer:
	  	$	480,000
	 Christopher B. Min, Vice President and Chief Financial Officer:
	  	$	250,000
	 (Commenced December 2007)
	  		
	 Steven C. Pollema, Vice President, Integrated Contact Solutions:
	  	$	300,000
	 And CRM (previous Chief Financial Officer)
	  		
	 Karen Bolton, Vice President:
	  	$	300,000
	 Christopher J. Danson, Vice President, Delivery:
	  	$	300,000
	 Steven H. Shapiro, Vice President, General Counsel And Corporate Secretary
	  	$	285,000

 All of the above executive officers have target bonus percentages as set forth in their employment agreements with
eLoyalty other than Mr. Min and Mr. Shapiro, who have target bonus amounts. 
 Additional information concerning the compensation of these officers
is set forth in the Proxy Statement on Form 14A filed by eLoyalty Corporation with the Securities and Exchange Commission.
# STATEOFLOUISIANA COURTOFAPPEAL,FIRSTCIRCUIT
STATE OFLOUISIANA NO. 2021 CW 1608 VERSUS DYLAN PIZZOLATO CONSOLIDATED WITH PRISCILLANOEL LEFEBURE VERSUS DYLAN JACOB PIZZOLATO InRe:

BEFORE: Katherine Reznik Benoit, applying writs, Family Court in and for the BatonRouge, No. 217897 c/w 218072. GUIDRY, HOLDRIDGE, AND CHUTZ, JJ. MARCH 14, 2022

for supervisory

Parish of East

WRIT GRANTED WITH ORDER. The family court's November 24, 2021 order which denied the motion to seal in forma pauperis exhibit filedby Katherine Benoit is reversed. Courts have noted that income tax returns are confidential innature and are of a personal character. Stolzle v. Safety & Sys. Assur. Consultants, Inc., 2002-1197 (La. 5/24/02), 819 So.2d 287, 289. Accordingly, the family court abused its discretion in denying the motion to seal the income tax return of Katherine Benoit. The motion to seal is granted, and this matter is remanded to the family court with instructions to seal the income tax return of Katherine Benoit attached to her motion to proceed in forma pauperis.

COURT OFAPPEAL, FIRST CIRCUIT

FOR THE COURT JMG GH WRC
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2799 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2799

    To extend the temporary reduction of duty on rubber basketballs.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

Mr. Kerry (for himself and Mrs. Murray) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To extend the temporary reduction of duty on rubber basketballs.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. RUBBER BASKETBALLS.

    (a) In General.--Heading 9902.13.09 of the Harmonized Tariff 
Schedule of the United States (relating to rubber basketballs) is 
amended by striking the date in the effective period column and 
inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
EXHIBIT 99.13





CONSENT OF LETICIA CONCA



Reference is made to the technical report
entitled “Amended NI 43-101 Technical Report on the Caspiche Project, Atacama Region, Chile” dated December 19, 2014
with an effective date of April 30, 2014 (the “PEA Report”), which contains certain scientific and technical information
related to the Caspiche property of Exeter Resource Corporation (the “Technical Report”).



I hereby consent to the inclusion of references
to my name and references to, and information derived from, the Technical Report, in this Annual Report on Form 40-F of Exeter
Resource Corporation, which is being filed with the United States Securities and Exchange Commission.



Dated this 27th  day of March, 2017.



|/s/ Leticia Conca                      | 
|-------------------------------------- | 
|Name:  Leticia Conca, Mining Engineer  | 
|SMEMember of Chilean Mining Commission |
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 07-1103

BRYAN O’NEAL BENSON,

Plaintiff - Appellant,

versus

BRAD PLEASANTS, Officer; S. A. SEFTON,

Officer,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern

District of North Carolina, at Raleigh. James C. Fox, Senior

District Judge. (5:06-cv-00058-F)

Submitted: June 15, 2007 Decided: June 20, 2007

Before WIDENER, MICHAEL, and KING, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Bryan O’Neal Benson, Appellant Pro Se. John A. Maxfield, COUNTY

ATTORNEY’S OFFICE FOR THE COUNTY OF WAKE, Raleigh, North Carolina;

Reid Russell, Julie Lynn Bell, PATTERSON, DILTHEY, CLAY, BRYSON &

ANDERSON, LLP, Raleigh, North Carolina, for Appellees.

Unpublished opinions are not binding precedent in this circuit.
*

Although this appeal was interlocutory at the time Benson

filed the notice of appeal, we possess jurisdiction to consider the

merits because the district court has subsequently entered final

judgment disposing of the remaining claims. See In re Bryson, 406

F.3d 284 (4th Cir. 2005). 

- 2 -

PER CURIAM:

Bryan O’Neal Benson appeals the district court’s order

granting in part and denying in part Defendants’ motion for summary

judgment and dismissing Benson’s claims against the Defendants in

their official capacities in his 42 U.S.C. § 1983 (2000) action.*

We have reviewed the record and find no reversible error.

Accordingly, we affirm for the reasons stated by the district

court. See Benson v. Pleasants, No. 5:06-cv-00058-F (E.D.N.C. Jan.

4, 2007). We dispense with oral argument because the facts and

legal contentions are adequately presented in the materials before

the court and argument would not aid the decisional process.

AFFIRMED
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2927 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2927

            To extend the temporary suspension of duty on e-
                 caprolactoneneopentylglycol copolymer.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Mr. Menendez introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
            To extend the temporary suspension of duty on e-
                 caprolactoneneopentylglycol copolymer.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. E-CAPROLACTONENEOPENTYLGLYCOL COPOLYMER.

    (a) In General.--Heading 9902.40.26 of the Harmonized Tariff 
Schedule of the United States (relating to e-
caprolactoneneopentylglycol copolymer) is amended by striking the date 
in the effective period column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

GALEN LLOYD HOUSER,

 Plaintiff - Appellant,

 v.

CARON GRANT-ELLIS; et al., 

 Defendants - Appellees.

No. 11-16492

D.C. No. 2:09-cv-00937-GMS

MEMORANDUM*

Appeal from the United States District Court

for the District of Arizona

G. Murray Snow, District Judge, Presiding

Submitted September 10, 2012** 

Before: WARDLAW, CLIFTON, and N.R. SMITH, Circuit Judges.

Arizona state prisoner Galen Lloyd Houser appeals pro se from the district

court’s dismissal order and summary judgment in his 42 U.S.C. § 1983 action

alleging deliberate indifference to his serious medical needs. We have jurisdiction

under 28 U.S.C. § 1291. We review de novo a dismissal under 28 U.S.C. § 1915A

FILED

SEP 19 2012

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 11-16492

for failure to state a claim, Resnick v. Hayes, 213 F.3d 443, 447 (9th Cir. 2000),

and the entry of summary judgment, Toguchi v. Chung, 391 F.3d 1051, 1056 (9th

Cir. 2004). We affirm.

The district court properly dismissed defendant Baird because Houser’s

allegations predicate liability solely upon Baird’s supervisory status. See Barren v.

Harrington, 152 F.3d 1193, 1194 (9th Cir. 1998) (order) (“Liability under § 1983

must be based on the personal involvement of the defendant.”). 

The district court properly dismissed defendant McMorran because Houser

failed to allege facts showing that McMorran knew of and disregarded an excessive

risk to his health or that McMorran’s alleged failure to act was anything more than

negligence. See Toguchi, 391 F.3d at 1058-59 (a prison official acts with

deliberate indifference only if he or she knows of and disregards an excessive risk

to the prisoner’s health and safety; negligence is insufficient to establish deliberate

indifference). 

The district court properly granted summary judgment because Houser failed

to raise a genuine dispute of material fact as to whether defendants Grant-Ellis and

Salyer were deliberately indifferent to Houser’s medical condition of severe

psoriasis. See id.; Hallett v. Morgan, 296 F.3d 732, 744-46 (9th Cir. 2002) (delay
3 11-16492

of medical treatment does not constitute deliberate indifference unless the delay led

to further injury).

We do not consider issues not specifically raised and argued in the opening

brief and the addendum to the opening brief, nor arguments and allegations raised

for the first time on appeal. See Padgett v. Wright, 587 F.3d 983, 985 n. 2 (9th Cir.

2009) (per curiam).

Houser’s contention that the district court erred in denying his request for

appointed counsel is unpersuasive. 

Houser’s petition for the redress of grievances, received on June 22, 2012, is

order filed and denied.

AFFIRMED.
# Fourth Court of Appeals

San Antonio, Texas

September 19, 2019

No. 04

- 19

- 00457

- CV

EX PARTE C.D.R.,

From the 63rd Judicial District Court, Val Verde County, Texas

Trial Court No. 33751

Ho norable Enrique Fernandez, Judge Presiding



### O R D E R

Lisa Traslavina ’ s n otificat ion of l a te r eporter’s r ecord is he reby NOTED. Time is

extended to September 20, 2019.

_________________________________ Rebeca C. Martinez, Justice

IN WITNESS WHEREOF, I have he reunto set my hand and affixed the seal of the said

court on this 19th day of September, 2019

.

___________________________________ Keith E . Hottle

, Clerk of Court
Exhibit 32.2  SECTION 906 CERTIFICATION  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the quarterly report of Medizone International, Inc. (the ACompany@) on Form 10-QSB for the quarter ended June 30, 2006, as filed with the Securities and Exchange Commission on the date hereof (the AReport@), I, Steve M. Hanni, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.   /s/ Steve M. Hanni Steve M. Hanni, Principal Financial Officer  Date: August 17, 2006  A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.